SUBSCRIBE
SUBSCRIBE

Gilead Sciences, Inc.

NEWS
Business
Gilead CFO Says Reliance On Outsourcing Helped It Bump Eli Lilly Out of Top 10 Ranking
May 22, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Achillion, Johnson & Johnson Hammer Out $1 Billion+ Hep C R&D Pact to Compete With Gilead and AbbVie
May 19, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Twitter Attempts to Marry Gilead, Achillion, Finds Reality Instead
May 19, 2015
 · 
7 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Here’s Why Gilead Should Avoid Bigger Deals and Focus on Smaller Cancer-Focused Buyouts
May 15, 2015
 · 
7 min read
BioCapital
Forget Gilead - This Tiny Biotech Offers A Much Richer Opportunity
May 12, 2015
 · 
1 min read
Business
Gilead’s CEO: One Breakthrough Drug After Another
May 7, 2015
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Gilead Finally Spends Some Money With $65 Million Buy
May 6, 2015
 · 
6 min read
Biotech Bay
Why The Street Keeps Doubting Gilead
May 5, 2015
 · 
1 min read
Biotech Bay
Why Gilead Will Probably Not Rush With The Vertex Acquisition
May 5, 2015
 · 
1 min read
Load More
  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Gilead Sciences, Inc. Presents Follow-Up Data From Zydelig Registrational Studies In Patients With Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma
December 8, 2014
 · 
11 min read
Biotech Bay
Gilead Sciences, Inc. Stock Rises After European Commission (EC) Market Authorization For Harvoni
November 18, 2014
 · 
6 min read
Biotech Bay
Gilead Sciences, Inc. Prices $4 Billion Of Senior Unsecured Notes
November 13, 2014
 · 
1 min read
Drug Development
Gilead Sciences, Inc. Announces Phase 2 Data For Investigational All-Oral Regimen Of Sofosbuvir Plus GS-5816 For The Treatment Of Chronic Hepatitis C
November 11, 2014
 · 
5 min read
Drug Development
Gilead Sciences, Inc. Announces Harvoni Study Results In Chronic Hepatitis C Patients With Advanced Liver Disease And Those Who Failed Prior Treatment
November 11, 2014
 · 
6 min read
Policy
Gilead Sciences, Inc. Submits New Drug Application To U.S. Food And Drug Administration For Tenofovir Alafenamide (TAF)-Based Single Tablet Regimen For HIV
November 6, 2014
 · 
4 min read
FDA
Johnson & Johnson, Medivir AB Snags U.S. Approval For Hepatitis C Combo With Gilead Sciences, Inc.
November 6, 2014
 · 
15 min read
Business
Gilead Sciences, Inc. Announces Third Quarter 2014 Financial Results
October 29, 2014
 · 
1 min read
BioForest
AHF To Gilead Sciences, Inc.: Do Your Patriotic Duty And Lower Hep. C Drug Prices For Veterans
October 24, 2014
 · 
1 min read
FDA
FDA Release: Gilead Sciences, Inc.'s Harvoni® (ledipasvir/sofosbuvir) Approved For The Treatment Of Chronic Hepatitis C, Genotype 1 Infection In Adults; Diplomat To Distribute
October 23, 2014
 · 
3 min read
Load More